ArriVent BioPharma, Inc. - AVBP

All tracked SEC files for this issuer. Showing up to 200 latest records.
Need parsed ownership details (13D/13G with shares/percent)? Open ownership details
Form 4 = insider transactions report. Form 144 = notice of proposed sale (not a completed trade confirmation).

Files summary

Total files loaded: 10
Latest filed: Aug 12, 2026
Form Count
8-K 4
4 4
SCHEDULE 13G/A 2

Latest files

Filed Form Report period Accession SEC
Aug 12, 2026 8-K Aug 11, 2026 0001104659-26-094869 View
Jul 27, 2026 SCHEDULE 13G/A 0002012383-26-002185 View
Jun 22, 2026 4 Jun 18, 2026 0001104659-26-076566 View
Jun 22, 2026 4 Jun 18, 2026 0001104659-26-076567 View
Jun 22, 2026 4 Jun 18, 2026 0001104659-26-076569 View
Jun 22, 2026 4 Jun 18, 2026 0001104659-26-076570 View
Jun 22, 2026 8-K Jun 18, 2026 0001104659-26-076352 View
May 11, 2026 8-K May 11, 2026 0001104659-26-058638 View
May 11, 2026 8-K May 11, 2026 0001104659-26-058706 View
May 06, 2026 SCHEDULE 13G/A 0000315066-26-001106 View